Showing Results for
- Academic Journals (10)
Search Results
- 10
Academic Journals
- 10
- Search Terms:
- 1From: Journal of Psychiatry and Neuroscience. (Vol. 35, Issue 3) Peer-ReviewedConsensus of opinion is rare in psychiatry. Even in the field of clinical trials, where experimentation is tightly controlled and regulatory bodies scrutinize the proof, controversies are frequent and difficult to...
- 2From: Journal of Psychiatry and Neuroscience. (Vol. 35, Issue 3) Peer-ReviewedHeinz Lehmann Award Dr. Pierre Blier is the recipient of the 2010 Canadian College of Neuropsychopharmacology (CCNP) Heinz Lehmann Award. Dr. Blier is a Professor in the Department of Psychiatry and Cellular and...
- 3From: Journal of Psychiatry and Neuroscience. (Vol. 35, Issue 3) Peer-ReviewedBackground: In spite of many similarities in the psychopathology of anorexia nervosa (AN) and bulimia nervosa (BN), the 2 groups seem to differ in terms of body image disturbances. Therefore, the aim of the present...
- 4From: Journal of Psychiatry and Neuroscience. (Vol. 35, Issue 3) Peer-ReviewedThe overdiagnosis of bipolar disorder An 18-year-old female student was referred to a mood disorders clinic by her psychiatrist with a diagnosis of bipolar disorder, type II, characterized by prominent "mood swings"...
- 5From: Journal of Psychiatry and Neuroscience. (Vol. 35, Issue 3) Peer-ReviewedBackground: Stress-induced dissociative states involving analgesia are a common feature of borderline personality disorder (BPD) and posttraumatic stress disorder (PTSD). Our aim was to investigate the psychologic,...
- 6From: Journal of Psychiatry and Neuroscience. (Vol. 35, Issue 3) Peer-ReviewedWe read with great interest the article by Witthaus and colleagues (1) recently published in the Journal of Psychiatry and Neuroscience. The authors found that, compared with controls, patients at ultra-high risk (UHR)...
- 7From: Journal of Psychiatry and Neuroscience. (Vol. 35, Issue 3) Peer-Reviewed
Hippocampal alterations in ultra-high risk patients are independent from medication and cannabis use
In their comment on our article entitled "Hippocampal subdivision and amygdalar volumes in patients in an at-risk mental state for schizophrenia," (1) Borgwardt and colleagues raise some critical questions regarding our... - 8From: Journal of Psychiatry and Neuroscience. (Vol. 35, Issue 3) Peer-ReviewedBackground: Brain imaging studies of major depressive disorder have shown alterations in the brain regions typically involved in episodic memory, including the prefrontal cortex and medial temporal areas. Some studies...
- 9From: Journal of Psychiatry and Neuroscience. (Vol. 35, Issue 3) Peer-ReviewedBackground: Patients with schizophrenia show elevated brain levels of the neuroactive tryptophan metabolite kynurenic acid (KYNA). This astrocyte-derived mediator acts as a neuroprotectant and modulates sensory gating...
- 10From: Journal of Psychiatry and Neuroscience. (Vol. 35, Issue 3) Peer-ReviewedBackground: Patients with schizophrenia frequently have deficits in social cognition, and difficulties in the discrimination of emotional facial expressions have been discussed as an important contributing factor. We...